NFAM1 spatially organizes lipid-raft-restricted DAPP1-PLCG2-Ca²⁺-NFAT1 signaling in monocyte-derived GAMs and represents a therapeutically targetable vulnerability in glioma.
Abstract
Background
Glioma-associated macrophages (GAMs) promote glioma progression, but the membrane-proximal mechanisms sustaining their tumor-supportive states remain poorly defined.
Methods
Bulk and single-cell transcriptomic analyses, human glioma specimens, GAM models, and orthotopic glioma models were used to define the expression and function of NFAM1. Lipid-raft fractionation, co-immunoprecipitation, proximity ligation, domain-mutant rescue, IP3 and Ca²⁺ measurements, and NFAT1 nuclear translocation assays delineated its signaling mechanism. Pharmacological, macrophage-depletion/reconstitution, and inducible genetic models evaluated its therapeutic relevance.
Results
NFAM1 was enriched in monocyte-derived, M2-like GAMs and associated with higher glioma grade, IDH-wild-type status, and poor survival. NFAM1 promoted GAM migration and M2-like polarization, thereby enhancing mesenchymal plasticity of glioma stem cells (GSCs), angiogenesis, and glioma progression. Mechanistically, phosphorylated NFAM1 recruited DAPP1 and PLCG2 through ITAM-SH2-dependent interactions within lipid rafts, organizing a spatially coordinated and functionally ordered signaling module. DAPP1 acted upstream of PLCG2 to promote IP3 production, Ca²⁺ signaling, and NFAT1 nuclear translocation. Madecassoside showed ITAM-dependent cellular target engagement with NFAM1, disrupted this signaling module, suppressed tumor-supportive GAM phenotypes, reduced orthotopic tumor growth, and prolonged survival. Its antitumor activity was markedly diminished after peripheral macrophage depletion or reconstitution with NFAM1-deficient bone marrow-derived macrophages. Moreover, inducible NFAM1 knockdown in reconstituted BMDM-derived GAMs after tumor establishment reduced tumor burden and extended survival.
Conclusions
NFAM1 spatially organizes lipid-raft-restricted DAPP1-PLCG2-Ca²⁺-NFAT1 signaling in monocyte-derived GAMs and represents a therapeutically targetable vulnerability in glioma.
ABSTRACT Glioblastoma multiforme (GBM), the most lethal type of primary brain tumor, exhibits profound metabolic plasticity driven by glioma stem cells (GSCs), which sustain therapeutic resistance and tumor recurrence. Here, we elucidate a novel epigenetic‐metabolic axis mediated by the histone acetyltransferase KAT7 t...
Ji-Long Liu, Yan-Fei Sun, Yue-Hua Zhu et al.· Advancement of science· 0 citations
Cancer-associated fibroblasts (CAFs) are the primary cellular source of extracellular matrix (ECM) in the tumor microenvironment (TME). Nevertheless, heterogeneity among CAF subsets results in substantial differences in their ECM-producing capacity, and definitive functional markers for the high ECM-producing CAF...
Shu-Bin Yu, Hui-Ya Xu, Bo-Xuan Zhou et al.· Journal of Experimental &...· 0 citations
It is suggested that GNAS-AS1 may contribute to the maintenance of M2-like characteristics in TAMs and facilitate CC progression, potentially through a mechanism involving miR-518c-5p sequestering, FBXO38 upregulation, and subsequent modulation of MAPK signaling.
Lin Zhang, Fang Zhao, Lin Zhang et al.· Molecular Carcinogenesis· 0 citations
Exosomal METTL16 from AML-MSCs plays a crucial role in promoting leukemic cell survival and M2 polarization, and targeting this axis may provide a potential theoretical foundation to reverse M2 macrophage polarization and inhibit AML progression.
Zhen Shang, Mi Zhou, Si-Jia Yan et al.· Biochimica et Biophysica Act...· 0 citations
Immunomodulatory therapies have emerged as promising treatments for cancer, where poly(I:C), a synthetic double-stranded RNA, is currently under clinical investigation for its ability to control myeloid cell function and T cell infiltration. While poly(I:C) mimics viral infection and activates Toll-like receptor 3...